Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (371-380 of 760) with videos related to

Pageof 76
Sort By:
Clinical Pharmacology and Therapeutics|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary InterventionDanwei Shao, Jean G Malavé, Joseph S Rossi, et al.
Journal of Thrombosis and Thrombolysis|May 27, 2011
Can resistance to aspirin be reversed after an additional dose?David Vivas, Esther Bernardo, Juan Carlos García-Rubira, et al.
Journal of the American College of Cardiology|June 3, 2004
Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studiesRaúl Moreno, Cristina Fernández, Fernando Alfonso, et al.
European Heart Journal|November 4, 2004
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variabilityDominick J Angiolillo, Antonio Fernández-Ortiz, Esther Bernardo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 28, 2006
Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late lossMarco A Costa, Manel Sabaté, Dominick J Angiolillo, et al.
The American Journal of Cardiology|December 10, 2008
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapyRoberta Rossini, Giuseppe Musumeci, Corrado Lettieri, et al.
Thrombosis and Haemostasis|October 25, 2013
Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery diseaseAndrew Darlington, Antonio Tello-Montoliu, Fabiana Rollini, et al.
The Journal of Invasive Cardiology|May 25, 2004
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile studyDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Clinical Chemistry|January 31, 2009
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromesLuigi M Biasucci, Giovanna Liuzzo, Roberta Della Bona, et al.
Journal of the American Heart Association|August 18, 2020
Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisDavide Capodanno, Marco Di Maio, Antonio Greco, et al.
Pageof 76

Showing results (371-380 of 760) with videos related to

Sort By:
Pageof 76
Clinical Pharmacology and Therapeutics|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary InterventionDanwei Shao, Jean G Malavé, Joseph S Rossi, et al.
Journal of Thrombosis and Thrombolysis|May 27, 2011
Can resistance to aspirin be reversed after an additional dose?David Vivas, Esther Bernardo, Juan Carlos García-Rubira, et al.
Journal of the American College of Cardiology|June 3, 2004
Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studiesRaúl Moreno, Cristina Fernández, Fernando Alfonso, et al.
European Heart Journal|November 4, 2004
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variabilityDominick J Angiolillo, Antonio Fernández-Ortiz, Esther Bernardo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 28, 2006
Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late lossMarco A Costa, Manel Sabaté, Dominick J Angiolillo, et al.
The American Journal of Cardiology|December 10, 2008
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapyRoberta Rossini, Giuseppe Musumeci, Corrado Lettieri, et al.
Thrombosis and Haemostasis|October 25, 2013
Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery diseaseAndrew Darlington, Antonio Tello-Montoliu, Fabiana Rollini, et al.
The Journal of Invasive Cardiology|May 25, 2004
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile studyDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Clinical Chemistry|January 31, 2009
Different apparent prognostic value of hsCRP in type 2 diabetic and nondiabetic patients with acute coronary syndromesLuigi M Biasucci, Giovanna Liuzzo, Roberta Della Bona, et al.
Journal of the American Heart Association|August 18, 2020
Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisDavide Capodanno, Marco Di Maio, Antonio Greco, et al.
Pageof 76